Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion via SRSF1 and functions as a biomarker in gastric cancer

Figure 2 Performance of HOXA11-AS in the diagnosis of gastric cancer. A: Serum HOXA11-AS levels in the samples obtained 1 d and 1 mo after surgery; B: The ROC curve demonstrates that serum HOXA11-AS can discriminate gastric cancer patients from healthy controls (AUC = 0.924, 95%CI: 0.881-0.967, P = 0.001) with a sensitivity of 78.7% and specificity of 97.8%. ^cP < 0.001. The assays were repeated three times. PreOp: Pre-operation; 1 d: The first day after surgical removal of the tumor; 1 mo: The 30^th day after surgical removal of the tumor; ROC: Receiver operating characteristic curve; AUC: Area under the curve.